BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 22529291)

  • 1. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
    Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
    Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Darwinian evolution and tiding clones in multiple myeloma.
    Bahlis NJ
    Blood; 2012 Aug; 120(5):927-8. PubMed ID: 22859708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
    Gralewski JH; Post GR; van Rhee F; Yuan Y
    Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia.
    Zatula A; Dikic A; Mulder C; Sharma A; Vågbø CB; Sousa MML; Waage A; Slupphaug G
    Oncotarget; 2017 Mar; 8(12):19427-19442. PubMed ID: 28038447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia.
    Engle EK; Fisher DA; Miller CA; McLellan MD; Fulton RS; Moore DM; Wilson RK; Ley TJ; Oh ST
    Leukemia; 2015 Apr; 29(4):869-76. PubMed ID: 25252869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.
    Lee Y; Yun J; Jeong D; Ryu S; Kwon SR; Yun H; Kim SM; Park JH; Lee DS
    Leuk Lymphoma; 2022 Feb; 63(2):385-394. PubMed ID: 34592901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse.
    Mlynarcikova M; Balcarkova J; Mickova P; Scudla V; Pika T; Bacovsky J; Minarik J; Janousova E; Jarosova M
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):358-65. PubMed ID: 27052024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
    Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P
    Ann Hematol; 2021 Feb; 100(2):437-443. PubMed ID: 33392702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.
    Melchor L; Brioli A; Wardell CP; Murison A; Potter NE; Kaiser MF; Fryer RA; Johnson DC; Begum DB; Hulkki Wilson S; Vijayaraghavan G; Titley I; Cavo M; Davies FE; Walker BA; Morgan GJ
    Leukemia; 2014 Aug; 28(8):1705-15. PubMed ID: 24480973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic complexity of multiple myeloma and its clinical implications.
    Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal competition with alternating dominance in multiple myeloma.
    Keats JJ; Chesi M; Egan JB; Garbitt VM; Palmer SE; Braggio E; Van Wier S; Blackburn PR; Baker AS; Dispenzieri A; Kumar S; Rajkumar SV; Carpten JD; Barrett M; Fonseca R; Stewart AK; Bergsagel PL
    Blood; 2012 Aug; 120(5):1067-76. PubMed ID: 22498740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia.
    Taniwaki M; Nishida K; Takashima T; Nakagawa H; Fujii H; Tamaki T; Shimazaki C; Horiike S; Misawa S; Abe T
    Blood; 1994 Oct; 84(7):2283-90. PubMed ID: 7919347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma.
    Binder M; Rajkumar SV; Ketterling RP; Dispenzieri A; Lacy MQ; Gertz MA; Buadi FK; Hayman SR; Hwa YL; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kyle RA; Kumar SK
    Blood Cancer J; 2016 Mar; 6(3):e401. PubMed ID: 26967818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
    Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma clonal evolution in homogeneously treated patients.
    Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
    Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.
    Walker BA; Wardell CP; Melchor L; Hulkki S; Potter NE; Johnson DC; Fenwick K; Kozarewa I; Gonzalez D; Lord CJ; Ashworth A; Davies FE; Morgan GJ
    Blood; 2012 Aug; 120(5):1077-86. PubMed ID: 22573403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal whole-genome sequencing reveals the evolution of MPAL.
    Zhang Y; Kang Z; Lv D; Zhang X; Liao Y; Li Y; Liu R; Li P; Tong M; Tian J; Shao Y; Huang C; Ge D; Zhang J; Bai W; Wang Y; Liu Q; Li Z; Yan J
    Cancer Genet; 2020 Jan; 240():59-65. PubMed ID: 31786363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.